Nantucket to Start Testing Wastewater for Drug Use

The popular island off Cape Cod plans to analyze its sewage for traces of drugs such as cocaine, fentanyl, opioids, methamphetamine, and nicotine. This initiative aims to monitor drug consumption patterns, especially during holidays and peak seasons, to better tailor recovery and outreach programs.

According to local health officials, this effort will provide concrete data on drug use trends, moving beyond assumptions to informed insights. “Understanding the actual level of drug activity helps us develop targeted interventions,” said Jerico Mele, the town’s human services director.

Biobot, a company specializing in wastewater epidemiology, will begin testing samples from the Surfside Wastewater Treatment Facility later this month. The results could facilitate collaborations with healthcare providers and rehab centers to support residents struggling with addiction, based on real-time data.

“If we know the typical usage levels, we can observe how interventions influence consumption and measure the effectiveness of our efforts,” Mele explained.

Funded by Nantucket’s long-standing wastewater testing program—initially implemented for COVID-19 in 2020—this new drug monitoring project aims to add another layer of public health surveillance. Although the results will not be publicly disclosed, access may be granted to healthcare partners to aid ongoing treatment efforts.

There’s no definitive evidence indicating a current drug crisis on the island, which has a year-round population of roughly 14,000. Historically, cocaine—particularly crack—was identified as the primary drug threat in the region, according to a 2001 report from the National Drug Intelligence Center.